Find trials
Search tips

Identification of Cytogenetic Abnormalities in Familial Monoclonal Gammopathies

Overview

About this study

Aim 1: To identify the specific cytogenetic subtypes associated with familial predisposition in MGUS.  Aim 2: To identify the proportion of patients with high risk MGUS among patients with familial MGUS

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • First degree relatives identified through the family study for a clinic visit and evaluation.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shaji Kumar, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Shaji Kumar M.D.

(507) 284-5096

Kumar.Shaji@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20317435

Mayo Clinic Footer